Zileuton Tablet, Extended Release
Product Images NDC 64980-206

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zileuton (NDC 64980-206). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zileuton Chemical Structure

FDA Label Image

Zileuton Container Label

Zileuton Container Label
This is a label of extended-release tablets of Zileuton that is prescribed to be dispensed with firost et for a certain duration. The label also includes some coding information along with the batch and manufacturing details. The reading direction of the label is not known, and the label size is 140 mm x 60mm.*
FDA Label Image

Zileuton Figure1

Zileuton Figure1
This is likely a table of results from a study comparing the effects of Zileuton Extended-Release Tablets to a placebo on some kind of endpoint. There are different timepoints listed, and numbers of individuals in the study at each timepoint. The numbers in the table appear to be some kind of measurement or result associated with the endpoint, but without additional context it's difficult to interpret what they represent.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.